Efficacy of raloxifene and bisphosphonate on bone marrow density and osteoporotic fracture outcomes in patients with rheumatoid arthritis

Trial Profile

Efficacy of raloxifene and bisphosphonate on bone marrow density and osteoporotic fracture outcomes in patients with rheumatoid arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2014

At a glance

  • Drugs Raloxifene (Primary) ; Bisphosphonates
  • Indications Osteoporosis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top